| Followers | 64 |
| Posts | 12265 |
| Boards Moderated | 0 |
| Alias Born | 01/28/2008 |
Tuesday, May 29, 2012 11:40:40 AM
Thank you Roag, much appreciated.
Maybe there's not much left in the way of assets, who knows?
But if business was that bad why not just say so?
And why not release the 10-K?
My thoughts can't help but drift back to when pps was shooting up, 8-K's coming out regularly, and a sky's-the-limit feel to this company.
Then news is clamped down, no fins, and pps suffers greatly.
Maybe all due to a failed M/A, but still it's hard to think their very survival depended on that M/A, whatever, or whoever, it was with.
Be glad to get some clarification, but right now I have to agree with you that this could very well go either way.
BOL
Maybe there's not much left in the way of assets, who knows?
But if business was that bad why not just say so?
And why not release the 10-K?
My thoughts can't help but drift back to when pps was shooting up, 8-K's coming out regularly, and a sky's-the-limit feel to this company.
Then news is clamped down, no fins, and pps suffers greatly.
Maybe all due to a failed M/A, but still it's hard to think their very survival depended on that M/A, whatever, or whoever, it was with.
Be glad to get some clarification, but right now I have to agree with you that this could very well go either way.
BOL
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
- Nasdaq Top 5 Premarket Losers • IH Market News • 05/20/2025 12:47:37 PM
- Protagenic Therapeutics Soars 190% on Merger to Launch Neuroactive Biopharma Firm • IH Market News • 05/19/2025 02:28:09 PM
- Nasdaq Top 5 Premarket Gainers • IH Market News • 05/19/2025 01:07:08 PM
